Navigation Links
Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra
Date:11/17/2009

BioSciences Inc. and Mate Hidvegi and planning to take all necessary steps to protect their rights in Hungary and in the United States.

According to Biropharma, the start of U.S. production of a product referring to Avemar is a series of violations of contractual rights that might make the Hungarian company go out of business.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

SOURCE Biropharma


'/>"/>
SOURCE Biropharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
2. Biomodels Scientists Report Development of a Novel Model for Cancer Treatment-Related Fatigue
3. Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference
4. Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA
5. Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference
6. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
7. Reportlinker Adds Cancer Vaccines: Measuring Market Potential
8. Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
9. Precision Antibody Wins Contract to Develop Gold Standard Antibodies as Part of National Cancer Institutes Clinical Proteomics Technologies for Cancer (CPTC) Initiative
10. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
11. Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Santa Clara CA (PRWEB) May 06, 2015 ... microscopy (AFM) today announced NX-Hivac, the only high vacuum ... and future needs for failure analysis semiconductor manufacturing. Park ... are interested in failure analysis solutions in highly doped ... are now required. , The high vacuum scanning ...
(Date:5/6/2015)... May 06, 2015 The Remedy ... growth strategy for the specialty pharmacy industry, will be ... 2015 Armada Specialty Pharmacy Summit. The Summit will be ... Las Vegas and is the largest annual gathering for ... in attendance, from pharmacy providers, pharma/biotech manufacturers, and payers, ...
(Date:5/5/2015)... 2015 Roka Bioscience, Inc. (NASDAQ: ROKA ), ... for the detection of foodborne pathogens,  today announced that ... America Merrill Lynch 2015 Health Care Conference on May 12 ... at the Wynn, Las Vegas NV. ... be available through the investor relations section of Roka Bioscience,s ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. Macromolecules ... acids undergo separation or are broken into ... biotechnological products. This separation requires various advanced ...
Breaking Biology Technology:Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 2Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2
... Technologies Inc. today announced that the Armed ... company's Invader analyte-specific reagents* (ASRs) exclusively for its cystic ... laboratory for the Army, Navy, Air Force, Public Health ... to screen select U.S. military personnel for genetic mutations ...
... this final installment of an interview with Carl Gulbrandsen, ... Gulbrandsen shares WARFs investment and portfolio strategy, WARFs perception ... insightful discussion of WARFs experience with software and information ... is Reaching Out to Businesses About Technology Developed in ...
... Amhaus, the image-conscious president of Spirit of Milwaukee , ... two ditzy women who worked at a Milwaukee brewery. The ... in respect to Amhaus) is banned from his vocabulary ... ,Frank Langley of Pel-Freez , a biotech firm that ...
Cached Biology Technology:Armed Forces Institute of Pathology Adopts Third Wave's Invader Screen 2WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 2
WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 3
WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy 4
From Rustbelt to Techtown: Milwaukee is Building a New Image and a New Economic Reality. 2From Rustbelt to Techtown: Milwaukee is Building a New Image and a New Economic Reality. 3
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... the Canadian Medical Association Journal shows that young farm ... the total population of young Canadian children to die ... analyzed Canadian data on fatal agricultural injuries to young ... strategies on farms and ranches. They found that children ...
... the Swedish University of Agricultural Sciences (SLU) report today about ... development of forest trees is controlled. In an article published ... gene that was previously shown to control the flowering time ... the help of this gene poplar trees can be stimulated ...
... potentially help researchers find new ways to avoid the ... existing drug compounds. , The study is being published ... Science, on May 5. , "The development of ... by the emergence of drug-resistant bacteria," says Geoffrey A. ...
Cached Biology News:Important gene controlling tree growth and development found 2Important gene controlling tree growth and development found 3New study reveals structure of E. coli multidrug transporter protein 2New study reveals structure of E. coli multidrug transporter protein 3
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Myeloid Marker (BM-1)...
Request Info...
Biology Products: